HF
QTTB icon

HRT Financial’s Q32 Bio QTTB Stock Holding History

HRT Financial’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+15,949
New +$133K ﹤0.01% 3398
2026
Q1 		– Sell
-24,698
Closed -$81K – 4916
2025
Q4 		$81K Buy
24,698
+9,862
+66% +$27.9K ﹤0.01% 2816
2025
Q3 		$29K Buy
+14,836
New +$28.5K ﹤0.01% 2665
2022
Q3 		– Sell
-800
Closed -$28K – 3623
2022
Q2 		$28K Buy
+800
New +$27.3K ﹤0.01% 2572
2022
Q1 		– Sell
-2,584
Closed -$169K – 4004
2021
Q4 		$169K Buy
2,584
+858
+50% +$83.3K ﹤0.01% 2595
2021
Q3 		$244K Buy
+1,726
New +$220K ﹤0.01% 2552
2021
Q1 		– Sell
-831
Closed -$168K – 3237
2020
Q4 		$168K Sell
831
-526
-39% -$102K ﹤0.01% 1539
2020
Q3 		$261K Buy
+1,357
New +$304K 0.01% 1228

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HRT Financial's QTTB Position: Q2 2026 in Review

HRT Financial opened a new position in Q32 Bio (QTTB) in Q2 2026: 15,949 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #3398 among its holdings. This is a return to the name: HRT Financial previously reported a position in QTTB as recently as Q4 2025.

HRT Financial first reported a position in QTTB in Q3 2020 and has held it in 8 quarters since. The position peaked at $261K in Q3 2020. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • HRT Financial held 15,949 shares of Q32 Bio worth $203K as of Q2 2026.
  • Q32 Bio was a new HRT Financial position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3398 holding.
  • HRT Financial first reported a position in Q32 Bio in Q3 2020 and has held it in 8 quarters since.
  • HRT Financial's Q32 Bio position peaked at $261K in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.